Literature DB >> 25660297

Angiotensin and neurovascular coupling: beyond hypertension.

Sherri Bloch1, Dima Obari, Hélène Girouard.   

Abstract

Brain homeostasis is dependent upon the constant perfusion of oxygen and nutrients through CBF. The mechanism responsible to couple CBF to neuronal activity is termed NVC. Ang II, a key player in hypertension, impairs NVC and has been found to be of significant importance in neurodegenerative diseases, such as AD. The presence of Ang II and its metabolites, as well as their receptors have been detected in many areas of the brain. Findings indicate that disruption of NVC by Ang II is mediated by its AT1R and NADPH oxidase (NOX)-dependent ROS production independently of its effect on blood pressure. Although the process causing ROS to interfere with NVC has yet to be elucidated, data label peroxynitrite as the leading ROS to do so. The same common pathway is involved in NVC impairment in AD experimental models. This review investigates recent data concerning the effects of Ang II on NVC with the intent of exploring new treatment perspectives for neurodegenerative diseases such as AD.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; angiotensin; blood pressure; neurovascular coupling; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 25660297     DOI: 10.1111/micc.12193

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  10 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 2.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

Review 3.  Binaural blood flow control by astrocytes: listening to synapses and the vasculature.

Authors:  Anusha Mishra
Journal:  J Physiol       Date:  2016-10-14       Impact factor: 5.182

4.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.

Authors:  Maximilian Wiesmann; Monica Roelofs; Robert van der Lugt; Arend Heerschap; Amanda J Kiliaan; Jurgen Ahr Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease.

Authors:  Carmen M Labandeira; Maria A Pedrosa; Aloia Quijano; Rita Valenzuela; Pablo Garrido-Gil; Mariña Sanchez-Andrade; Juan A Suarez-Quintanilla; Ana I Rodriguez-Perez; Jose L Labandeira-Garcia
Journal:  NPJ Parkinsons Dis       Date:  2022-06-14

Review 6.  Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

Authors:  Edith Hamel; Jessika Royea; Brice Ongali; Xin-Kang Tong
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

7.  Effect of Acupuncture at LR3 on Cerebral Glucose Metabolism in a Rat Model of Hypertension: A 18F-FDG-PET Study.

Authors:  Jing Li; Yumei Wang; Kejie He; Chong Peng; Peilong Wu; Chenyun Li; Xinsheng Lai
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-26       Impact factor: 2.629

Review 8.  Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.

Authors:  Murat Oz; Dietrich Ernst Lorke
Journal:  Biomed Pharmacother       Date:  2021-01-05       Impact factor: 6.529

Review 9.  Targeting Renin-Angiotensin System Against Alzheimer's Disease.

Authors:  Abadi Kahsu Gebre; Birhanetensay Masresha Altaye; Tesfay Mehari Atey; Kald Beshir Tuem; Derbew Fikadu Berhe
Journal:  Front Pharmacol       Date:  2018-04-30       Impact factor: 5.810

10.  Effect of Resveratrol on Reactive Oxygen Species-Induced Cognitive Impairment in Rats with Angiotensin II-Induced Early Alzheimer's Disease .

Authors:  Yu-Te Lin; Yi-Chung Wu; Gwo-Ching Sun; Chiu-Yi Ho; Tzyy-Yue Wong; Ching-Huang Lin; Hsin-Hung Chen; Tung-Chen Yeh; Chia-Jung Li; Ching-Jiunn Tseng; Pei-Wen Cheng
Journal:  J Clin Med       Date:  2018-10-05       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.